Sanara MedTech/SMTI

$38.49

-1.18%
-
1D1W1MYTD1YMAX

About Sanara MedTech

Sanara MedTech Inc. is a medical technology company. The Company is focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical, chronic wound and skincare markets. It has products across surgical and chronic wound care applications and has multiple products in its pipeline. Its surgical products include CellerateRX Surgical Activated Collagen, TEXAGEN, BiFORM, AMPLIFY and ALLOCYTE, FORTIFY TRG Tissue Repair Graft, and FORTIFY FLOWABLE Extracellular Matrix are used in a range of surgical specialties to help promote patient healing and reduce the risk of complications. Its chronic wound care products include HYCOL Hydrolyzed Collagen, BIAKOS Antimicrobial Skin and Wound Cleanser and BIAKOS Antimicrobial Wound Gel, are targeted for use across the post-acute continuum of care, including home health, hospice, physician offices, podiatrists, retail, skilled nursing facilities and wound care clinics.

Ticker

SMTI

Sector

Healthcare

Trading on

NASDAQ

Industry

Biotechnology & Drugs

CEO

Zachary Fleming

Employees

101

Headquarters

Fort worth, United States

Sanara MedTech Metrics

BasicAdvanced
$332.66M
Market cap
-
P/E ratio
-$1.00
EPS
1.58
Beta
-
Dividend rate

What the Analysts think about Sanara MedTech

Analyst Ratings

Majority rating from 1 analysts.
Buy

Price Targets

Average projection from 1 analysts.
27.31% upside
High $49.00
Low $49.00
$38.49
Current price
$49.00
Average price target

Sanara MedTech Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-6.25% profit margin
QuarterlyAnnual
Q3 23
QoQ growth
Revenue
$16M
1.91%
Net income
$-1M
-44.44%
Profit margin
-6.25%
-45.46%

Sanara MedTech Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 0%
QuarterlyAnnual
Q4 22
Q1 23
Q2 23
Q3 23
Q4 23
Actual
-$0.38
-$0.14
-$0.22
-$0.13
-
Expected
-$0.26
-$0.33
-$0.13
$0.00
-$0.13
Surprise
46.15%
-57.58%
69.23%
-∞%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

Buy or sell Sanara MedTech stock

Buy or sell Sanara MedTech stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing